Severe COVID-19: How are these patients today

Morgado, Sara Andreia Góis; Matias, Margarida V.; Brysch, Eva; Santos, Ana A.; Torres, João Sousa; Rebelo, Marta; Carmo, Eduarda; Nogueira, Fernando

doi:10.2478/pneum-2025-0002

Figures & Tables

Imaging evaluation_

			Up to 6 months post-discharge		7–12 months post-discharge		13–18 months post-discharge		>18 months post-discharge
Patient	Age (years)	Sex	Months	Findings	Months	Findings	Months	Findings	Months	Findings
1	56	M	4	OP	x	x	x	x	21	PFr
2	68	M	4	OP	10	GGO + PFr	x	x	22	GGO + PFr
3	70	F	3	GGO	12	GGO subtle	x	x	24	GGO subtle
4	67	F	5	PFr	12	PFr	x	x	x	x
5	55	M	2	GGO	8	GGO	x	x	24	GGO
6	75	F	4	GGO + PF	x	x	x	x	x	x
7	72	M	5	GGO + OP	12	N	x	x	24	N
8	72	F	5	GGO	12	PFr	x	x	23	PFr
9	66	F	5	N	x	x	x	x	x	x
10	63	M	3	PF	11	PF	x	x	24	PFr
11	72	F	6	GGO	x	x	x	x	x	x
12	81	F	6	GGO + PFr	12	PFr	x	x	x	x
13	62	M	x	x	7	PF	18	GGO + PF	x	x
14	69	F	3	GGO	10	GGO	x	x	x	x
15	77	F	2	GGO	7	GGO	x	x	20	GGO subtle
16	63	F	3	GGO	x	x	x	x	x	x
17	72	F	5	N	11	N	x	x	24	N
18	77	M	5	GGO	x	x	x	x	x	x
19	68	M	5	PF; 16 mm nodule in the RUL – primary lung adenocarcinoma	x	x	13	PF	26	PF
20	67	M	3	GGO	x	x	x	x	20	GGO
21	66	M	6	N	x	x	x	x	x	x
22	70	M	x	x	7	GGO	18	N	x	x
23	62	F	4	N	x	x	15	N	x	x
24	52	F	3	GGO	7	GGO	x	x	x	x
25	75	M	6	GGO + PF	9	PFr	x	x	x	x
26	67	M	x	x	7	GGO + PFr	x	x	x	x
27	71	M	x	x	9	PFr	17	OP	22	PFr
28	70	F	x	x	7	GGO	x	x	x	x
29	46	M	x	x	7	N	15	N	x	x
30	46	F	x	x	12	N	x	x	x	x
31	40	M	4	N	x	x	x	x	x	x
32	77	F	5	GGO	x	x	13	GGO	x	x

Respiratory functional evaluation_

				Up to 6 months post-discharge									7-12 months post-discharge									>12 months post-discharge
Patient	Age (years)	Sex	Months	FVC (%)	FEV₁ (%)	FEV₁/FVC (%)	TLC (%)	DLCO (%)	DLCO/VA (%)	PIM (%)	PEM (%)	Months	FVC (%)	FEV₁ (%)	FEV₁/FVC (%)	TLC (%)	DLCO (%)	DLCO/VA (%)	PIM (%)	PEM (%)	Months	FVC (%)	FEV₁ (%)	FEV₁/FVC (%)	TLC (%)	DLCO (%)	DLCO/VA (%)	PIM (%)	PEM (%)
1	56	M	4	93	100	85.9	80	91	116	144	110	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	X
2	68	M	4	95	103	83.65	81	72	86	58	50	12	103	116	86.99	x	94	106	71	62	x	x	x	x	x	x	x	X	x
3	70	F	4	89	94	88.37	80	60	81	60	94	12	104	111	88.84	x	64	89	122	184	x	x	x	x	x	x	x	x	x
4	67		F	5	No acceptability criteria	12		93	90	79.84	xxx	60		54				x	x	x		x	x		x	x		x	x
5	55	M	2	103	118	90.27	90	82	92	107	74	11	121	125	81.57	x	76	79	x	x	x	x	x	x	x	x	x	x	x
6	75	F	x	x	x	x	x	x	x	x	X	7	101	110	83.34	77	79	106	62	58	x	x	x	x	x	x	x	x	x
7	72	M	x	x	x	x	x	x	x	x	x	12	83	87	79.26	x	98	139	60	58	x	x	x	x	x	x	x	x	X
8	72	F	5	105	108	84.41	89	68	83	126	70	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
9	66	F	5	107	104	80.67	85	68	88	105	78	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
10	63	M	4	115	116	78.95	89	75	83	79	67	x	x	x	x	x	x	x	x	X	22	99	103	80.35	x	68	87	x	x
11	72	F	5	138	138	79.54	112	92	87	122	110	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
12	81	F	5	107	119	79.97	82	67	88	120	98	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
13	62	M	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	16	110	107	75.56	x	95	103	103	70
14	69	F	5	104	103	80.87	81	49	66	164	141	x	x	x	x	x	x	x	x	x	13	103	104	82.12	x	64	82	x	x
15	77	F	2	100	100	80	90	70	85	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
16	63	F	3	91	98	89.92	85	60	75	113	90	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
17	72	F	5	121	116	79.77	107	91	90	106	155	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
18	77	M	4	96	101	79.2	95	55	69	71	66	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
19	68	M	5	101	108	82.18	85	48	60	92	68	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
20	67	M	5	78	73	72.75	69	47	72	90	78	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
21	67	M	6	107	105	76.23	89	86	102	60	41	x	x	x	x	x	x	x	x	x	18	115	118	79.9	x	x	x	x	x
22	66	M	x	x	x	x	x	x	x	x	x	11	90	100	86.3	x	83	119	106	85	x	x	x	x	x	x	x	x	x
23	70	M	x	x	x	x	x	x	x	x	x	9	113	115	78.18	x	86	88	x	x	x	x	x	x	x	x	x	x	x
24	62	F	5	111	108	81.8	x	86	94	162	157	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
25	52	F	3	120	115	81.97	106	78	84	45	48	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
26	75	M	5	106	112	79.71	80	62	82	103	55	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
27	67	M	1	113	109	74.96	x	79	79	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
28	71	M	x	x	x	x	x	x	x	x	x	8	98	114	88.42	67	51	80	120	101	x	x	x	x	x	x	x	x	x
29	70	F	6	80	80	73.91	81	66	98	120	86	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
30	77	F	4		No acceptability criteria	x		x	x	x	x		x	x	x	x		18	80	94		93.29	x	x		x	x	x

Severe COVID-19: How are these patients today

Figures & Tables

Imaging evaluation_

Respiratory functional evaluation_

Paradigm

My account